Report ID |
138198 |
Drug Identification Number |
02012472 |
Brand name |
LOVENOX |
Common or Proper name |
Lovenox |
Company Name |
SANOFI-AVENTIS CANADA INC |
Market Status |
MARKETED |
Active Ingredient(s) |
ENOXAPARIN SODIUM |
Strength(s) |
30MG |
Dosage form(s) |
SOLUTION |
Route of administration |
SUBCUTANEOUS
SUBCUTANEOUS |
Packaging size |
10 |
ATC code |
B01AB |
ATC description |
ANTITHROMBOTIC AGENTS |
Reason for shortage |
Delay in shipping of the drug. |
Anticipated start date |
2021-12-10 |
Actual start date |
2021-12-10 |
Estimated end date |
2022-01-14 |
Actual end date |
2022-01-06 |
Shortage status |
Resolved |
Updated date |
2022-01-13 |
Company comments |
The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |